Organic farming requires cultivars that are specifically adapted to this low input cropping system. Hence, organic farmers and scientists joined in a participatory breeding approach to develop region-specific genotypes of spring faba bean for organic conditions in Germany. A set of 49 genotypes with contrasting degrees of heterozygosity and heterogeneity was used in field trials across five locations in Germany during 3 years 2004, 2005 and 2006. The material involved 18 inbred lines, their 18 polycross progenies, one blend of inbred lines, one blend of polycross progenies, one blend of hybrids and ten checks. Inbred lines are uniform, thus giving the option to be specifically adapted; whereas the polycross progenies and synthetics (Syn-1; predicted from the inbred lines and polycross progenies performance) are partly heterogeneous and heterozygous, thus giving the option to evolve. Agronomic performance was assessed and a ''personal appreciation'' score of the material was assigned to each genotype by each partner. This personal appreciation was strongly influenced by biotic and abiotic constraints faced by the crop in each location and by the expected grain yield of the genotypes. Uniformity was apparently appreciated by organic farmers. In all locations, the highest yielding inbred line yielded slightly better than the predicted highest yielding synthetic. However, this slight disadvantage of the synthetic is very likely to disappear if the synthetic (Syn-1) is propagated during successive generations.

No abstract

No abstract

Riboflavin (vitamin B2) is essential for monogastric animals. It is mainly produced by recombinant microorganisms (Candida famata, Bacillus subtilis and Ashbya gossypii). The availability of genetically modified organism (GMO)-free riboflavin, obligatory in European organic agriculture, is a major issue. Besides, requirements for organic livestock might differ from conventional production because other genotypes and feed formulations are used. The effects of a fermentation suspension with a high native content of riboflavin produced with unmodified A. gossypii by fermentation were investigated at graded dosages as an alternative to conventional (GMO-based) riboflavin in slow-growing broilers on performance traits and health and welfare indicators. In 2 runs with 800 animals each, Ranger Gold™ broilers were fed with 4 dietary treatments. For starter diets (day 1 to 18), treatments included a basal diet (1) without any riboflavin supplementation (negative control, N-C), (2) with conventional riboflavin supplementation (Cuxavit B2 80% riboflavin) at 9.6 mg/kg (positive control, P-C), (3) with riboflavin supplementation from the alternative source at 3.5 mg/kg (A-low) and (4) with riboflavin supplementation from the alternative source at 9.6 mg/kg (A-high). For the finisher diet (day 29 until slaughtering), P-C and A-high were supplemented with 8.0 mg/kg and A-low with 3.5 mg/kg. Diets were formulated according to organic regulations. Animals were kept in floor pens with 20 chickens per pen. Weekly, BW, feed and water consumption were recorded. Every second week, animal-based health and welfare indicators (feather score and footpad dermatitis) were scored. Slaughter traits were assessed for five males and females per pen at 62/63 days of age. Final body weight of A-high differed from N-C and A-low, but not from P-C. From week 2 until six years of age, A-high had a higher daily weight gain when compared to all other groups. With 74.4%, dressing percentage was higher in A-high compared with all other groups (73.3%). Breast percentage of A-low was lower than that of both control groups but did not differ from A-high. The highest frequency of liver scores indicating fatty liver syndrome was found in P-C, followed by N-C and A-low. Feather scores did not respond to treatment; the highest frequency of mild footpad dermatitis was observed in A-high, however at a low prevalence. In conclusion, the tested fermentation suspension with a high native content of riboflavin derived from fermentation of A. gossypii can be used at levels of commercial recommendations as alternative to riboflavin produced from GMO in broiler feeding. Further studies must verify whether riboflavin can be reduced without inducing riboflavin deficiency in slow-growing broilers.

No abstract